Company intelligence / Profile preview

American Peptide Company

Sunnyvale, California, United Statesbiocomcro.org ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

American Peptide Company was a leading US-based manufacturer specializing in the production of research-grade and GMP-grade peptides and peptide APIs. It provided comprehensive services from pre-clinical through commercial scale including process development, analytical validation, stability studies, regulatory support for CMC/DMF filings. The company did not develop its own clinical pipeline but enabled drug development for clients across pharma/biotech.

Therapeutic areas: Other
Modalities: PeptidesPeptide-drug conjugateProteinSmall moleculePEGylated peptides/proteins
Industry: Contract Manufacturing Organization

Partnerships

Operated as an independent supplier to pharmaceutical/biotech companies prior to acquisition by Bachem

Beyond the preview

Go deeper on American Peptide Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Peptide Company.

Explore the full profile